Bioxytran, Inc (BIXT): Operating Income
-$1.84M
Year ended 2025-12-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.84M | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$2.22M | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$3.80M | n/m | 2025-04-03, From 2023-01-01 |
| 2022-12-31 | -$2.44M | n/c | 2025-01-13, From 2022-01-01 |
| 2021-12-31 | -$4.21M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$1.27M | n/m | 2022-04-11, From 2020-01-01 |
| 2019-12-31 | -$1.63M | n/m | 2021-04-09, From 2019-01-01 |
| 2018-12-31 | -$215.1K | n/m | 2020-03-18, From 2018-01-01 |
| 2017-12-31 | -$310.6K | n/m | 2018-04-02, From 2017-01-01 |
| 2016-12-31 | -$671.3K | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$2.09M | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$1.28M | n/m | 2016-09-20, From 2014-01-01 |
| 2013-12-31 | -$1.97M | n/m | 2015-04-10, From 2013-01-01 |
| 2012-12-31 | -$2.29M | n/m | 2014-04-14, From 2012-01-01 |
| 2011-12-31 | -$4.43M | n/m | 2013-04-15, From 2011-01-01 |
| 2010-12-31 | -$329.0K | n/a | 2012-12-31, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Bioxytran, Inc (BIXT) | 2025-12-31 | -$1.84M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$5.29M | n/m |
| Ocean Biomedical, Inc. (OCEA) | 2024-12-31 | -$3.80M | n/m |
| Bio Essence Corp (BIOE) | 2025-12-31 | $900.0K | n/m |
| NeuroSense Therapeutics Ltd. (NRSN) | 2025-12-31 | -$11.09M | n/m |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$10.55M | n/m |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$994.6K | n/m |
| ZyVersa Therapeutics, Inc. (ZVSA) | 2025-12-31 | -$25.49M | n/m |
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | -$19.35M | n/m |
Compare BIXT, PVCT, OCEA, BIOE side by side · Screen every company in Pharmaceutical Preparations ↗